Teva Records $646M Expense For Legal Settlements, Including Opioid Litigation

Mealey's (August 14, 2019, 1:47 PM EDT) -- PETACH TIKVA, Israel — Drug manufacturer Teva Pharmaceutical Industries Ltd. on Aug. 7 told stockholders that in the second quarter, it recorded an expense of $646 million in legal settlements and loss contingencies, up from $20 million for the comparable period last year....

Related Sections